You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 15, 2024

Details for Patent: 8,613,947

✉ Email this page to a colleague

« Back to Dashboard

Which drugs does patent 8,613,947 protect, and when does it expire?

Patent 8,613,947 protects CYCLOSET and is included in one NDA.

This patent has twenty-two patent family members in twelve countries.

Summary for Patent: 8,613,947

Title:	Bromocriptine formulations
Abstract:	The present application describes pharmaceutical formulations of bromocriptine mesylate and methods of manufacturing and using such formulations. The formulations are useful for improving glycemic control in the treatment of type 2 diabetes.
Inventor(s):	Cincotta; Anthony H. (Tiverton, RI), Bowe; Craig Michael (Encinitas, CA), Steams; Paul Clark (San Diego, CA), Weston; Laura Jean (Escondido, CA)
Assignee:	VeroScience LLC (Tiverton, RI)
Application Number:	13/773,500
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Dosage form; Use;

Drugs Protected by US Patent 8,613,947

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Veroscience	CYCLOSET	bromocriptine mesylate	TABLET;ORAL	020866-001	May 5, 2009		RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up	Y			IMPROVEMENT OF GLYCEMIC CONTROL IN INDIVIDUALS WITH TYPE 2 DIABETES	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent 8,613,947

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	091351	⤷ Sign Up
Australia	2013256558	⤷ Sign Up
Australia	2016202572	⤷ Sign Up
Australia	2018203021	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.